Mechanisms of allergen‐specific immunotherapy
Open Access
- 1 June 2000
- Vol. 55 (6), 522-530
- https://doi.org/10.1034/j.1398-9995.2000.00120.x
Abstract
No abstract availableKeywords
This publication has 89 references indexed in Scilit:
- Skin test evaluation of genetically engineered hypoallergenic derivatives of the major birch pollen allergen, Bet v 1: Results obtained with a mix of two recombinant Bet v 1 fragments and recombinant Bet v 1 trimer in a Swedish population before the birch pollen season☆☆☆★Journal of Allergy and Clinical Immunology, 1999
- Modification of a Major Peanut Allergen Leads to Loss of IgE BindingInternational Archives of Allergy and Immunology, 1999
- Effects of peptide therapy on ex vivo T-cell responsesJournal of Allergy and Clinical Immunology, 1998
- Recombinant allergen fragments as candidate preparations for allergen immunotherapyJournal of Allergy and Clinical Immunology, 1997
- Nasal Immunotherapy in Weed-Induced Allergic RhinitisAnnals of Allergy, Asthma & Immunology, 1997
- IL-10: a potential therapy for allergic inflammation?Immunology Today, 1997
- The expanding universe of T-cell subsets: Th1, Th2 and moreImmunology Today, 1996
- Antigen focusing by specific monomeric immunoglobulin E bound to CD23 on Epstein-Barr virus-transformed B cellsHuman Immunology, 1993
- Studies on allergoids from naturally occurring allergens III. Preparation of ragweed pollen allergoids by aldehyde modification in two stepsJournal of Allergy and Clinical Immunology, 1981
- Controlled evaluations of repository therapy in ragweed hay feverJournal of Allergy, 1967